SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-20-016206
Filing Date
2020-07-16
Accepted
2020-07-16 17:01:15
Documents
2
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A brhc10013467_sc13da.htm SC 13D/A 113637
2 JOINT FILING AGREEMENT brhc10013467_99-1.htm EX-99.1 6922
  Complete submission text file 0001140361-20-016206.txt   122235
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Subject) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87630 | Film No.: 201031988
SIC: 2836 Biological Products, (No Diagnostic Substances)